首页|1990-2019年亚洲主要国家与全球宫颈癌疾病负担变化趋势分析

1990-2019年亚洲主要国家与全球宫颈癌疾病负担变化趋势分析

扫码查看
目的 分析 1990-2019 亚洲主要国家及全球宫颈癌疾病负担,为制定宫颈癌防控策略提供科学依据.方法 收集1990-2019 年全球疾病负担研究(global burden of disease,GBD)数据,利用发病、死亡、伤残调整寿命年(disa-bility-adjusted life years,DALY)等指标定量评估宫颈癌的疾病负担情况,采用估计百分百变化(estimated annual percent change,EAPC)分析疾病负担时间变化趋势.结果 1990-2019 年,全球宫颈癌标化发病率从 7.64/10 万下降至 6.81/10万,标化死亡率从 4.46/10 万降低至 3.40/10 万,标化DALY率从 139.98/10 万下降至107.20/10 万,年平均降低分别为0.39%、0.96%、0.94%(EAPC<0,P<0.05).亚洲主要国家中,中国的标化发病率从 4.20/10 万上升至 5.53/10 万,平均每年增长1.63%(EAPC>0,P>0.05).中国宫颈癌的死亡数从2.64 万增加到5.34 万,相对增长1.02 倍,全球及亚洲主要国家标化死亡率、标化DALY率均呈逐年下降趋势,而中国未出现下降趋势.相关分析显示,发病率与社会人口指数(socio-demographic index,SDI)无明显相关性(ρ=-0.13,P=0.11),死亡率与SDI呈负相关(ρ=-0.74,P<0.001),DALY与SDI也呈负相关(ρ=-0.77,P<0.001).结论 中国宫颈癌的标化发病率、死亡率逐年增加,疾病负担呈上升趋势,应积极采取科学有效的防控措施,降低宫颈癌疾病负担.
Analysis of the Changing Trends in the Disease Burden of Cervical Cancer in Major Asian Countries and Globally from 1990 to 2019
Objective To analyze the disease burden of cervical cancer in major Asian countries and globally from 1990 to 2019,which help to provide reference for the prevention and control of cervical cancer.Methods We utilized data from the(Global Burden of Disease,GBD)2019 database,and our analysis incorporated key measures such as incidence,deaths and(Disability-Adjusted Life Years,DALY)to quantitatively assess the global impact of cervical cancer.We employed the(Estimated Annual Percent Change,EAPC)to analyze the time trends in the disease burden.Results From 1990 to 2019,the global standardized incidence rate of cervical cancer decreased from 7.64/100,000 to 6.81/100,000,while the standardized death rate decreased from 4.46/100,000 to 3.40/100,000.The standardized DALYrate also decreased from 139.98/100,000 to 107.20/100,000.The annual average reductions were 0.39%,0.96%,and 0.94%,respectively(EAPC<0,P<0.05).Among major Asian countries,China's standardized incidence rate increased from 4.20/100,000 to 5.53/100,000,with an average annual growth of 1.63%(EAPC>0,P>0.05).The number of cervical cancer deaths in China increased from 26,400 to 53,400,representing a relative increase of 1.02 times.While the standardized mortality rate and standardized DALY rate for cervical cancer decreased globally and in major Asian countries,China did not exhibit a declining trend.Relevant analysis revealed no significant correlation between incidence rate and(Socio-Demographic Index,SDI)(ρ=-0.13,P=0.11).However,mortality rate showed a negative correlation with SDI(ρ=-0.74,P<0.001),and DALY also exhibited a negative correlation with SDI(ρ=-0.77,P<0.001).Conclusion The standardized incidence and death rates of cervical cancer in China have been increasing year by year,and the disease burden is on the rise.It is imperative to proactively implement scientifically effective prevention and control measures to reduce the burden of cervical cancer.

Cervical cancerBurden of diseaseDisability-adjusted life years(DALY)Time trends

何贤英、王振博、初云天、赵杰、崔芳芳

展开 >

郑州大学第一附属医院(450052)

互联网医疗系统与应用国家工程实验室

浦江国家实验室

宫颈癌 伤残调整寿命年 疾病负担 时间趋势

科技创新2030"新一代人工智能"重大项目河南省科技攻关计划项目

2022ZD0160705232102311057

2024

中国卫生统计
中国卫生信息学会 中国医科大学

中国卫生统计

CSTPCD北大核心
影响因子:1.172
ISSN:1002-3674
年,卷(期):2024.41(4)
  • 5